Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 235.00
-1.00 (-0.42%)
May 13, 2026, 4:25 PM CET
Medistim ASA Market Cap
Medistim ASA has a market cap or net worth of 4.3 billion as of May 14, 2026. Its market cap has increased by 47.27% in one year.
Market Cap
4.30B
Enterprise Value
4.12B
Revenue
719.89M
Ranking
n/a
PE Ratio
27.54
Stock Price
235.00
Market Cap Chart
Since May 28, 2004, Medistim ASA's market cap has increased from 40.53M to 4.30B, an increase of 10,507.38%. That is a compound annual growth rate of 23.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 4.30B | -9.22% |
| Dec 30, 2025 | 4.74B | 72.95% |
| Dec 30, 2024 | 2.74B | -30.01% |
| Dec 29, 2023 | 3.91B | -7.22% |
| Dec 30, 2022 | 4.22B | -37.01% |
| Dec 30, 2021 | 6.69B | 47.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.67B |
| Nordhealth AS | 1.99B |
| Photocure ASA | 1.68B |
| Thor Medical ASA | 1.62B |
| ArcticZymes Technologies ASA | 1.06B |
| Nykode Therapeutics AS | 1.03B |
| Vistin Pharma ASA | 993.32M |
| Lytix Biopharma ASA | 815.14M |